Consistent with these findings, upregulation of CD36 expression induced resistance to gemcitabine in PDAC-resistant cells[58] or chemoresistance in acute myeloid leukemia (AML) cells[59] [Table 2]. Here, CD36 is linked to acute myeloid leukemia.